Synthetic Data Utilization in Clinical Trials

This fact sheet outlines the innovative use of synthetic data in clinical trials, focusing on the product Simulants developed by Medidata. The document explains how synthetic data can unlock and accelerate research and development by providing insights from historical clinical trial data while safeguarding patient privacy and intellectual property. It details the barriers to accessing clinical trial data, including regulatory requirements and privacy concerns, which have historically limited data sharing. The emergence of generative AI allows for the creation of synthetic datasets that mimic the properties of original data without compromising sensitive information. The fact sheet further describes the capabilities of Simulants, including its ability to generate high-fidelity synthetic data from a vast repository of clinical trial data, thereby enhancing research accuracy and optimizing trial design. Additionally, it highlights the ethical considerations of using synthetic data, such as respecting patient consent and promoting trust within the medical research community.